切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - AMPA receptor - D1 and D5 Receptors - CREBBP

8 件产品

每页
清除全部
  1. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  2. Fenoldopam
    B1483 Fenoldopam
    中文名: 非诺多泮
    Target: D1 and D5 Receptors
    Summary: D1样多巴胺受体部分激动剂
      ≥15.29 mg/mL
      ≥12.55 mg/mL
  3. Pergolide mesylate
    B1485 Pergolide mesylate
    中文名: 甲磺酸培高利特
    Target: D1 and D5 Receptors|D2 Receptors
    Summary: 多巴胺能激动剂
      ≥6.84 mg/mL
      insoluble in H2O
  4. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  5. Clozapine
    B2235 Clozapine
    中文名: 氯氮平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 Receptors
    Summary: 5-HT受体拮抗剂
      ≥14.95 mg/mL
      insoluble in H2O
  6. Thioridazine HCl
    A8537 Thioridazine HCl
    中文名: 盐酸硫利达嗪,盐酸硫代利哒,甲硫达嗪盐酸盐,甲硫哒嗪盐酸盐
    Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 钙通道蛋白抑制剂
      ≥20.35 mg/mL
      ≥6.78 mg/mL
  7. SGC-CBP30
    A4491 SGC-CBP30
     2 Citation
    Target: CREBBP|EP300
    Summary: CREBBP/EP300 bromodomain抑制剂
      ≥20.05 mg/mL
      ≥4.67 mg/mL
  8. I-CBP 112
    A4490 I-CBP 112
    Target: CREBBP|EP300
    Summary: CBP/EP300 bromodomain抑制剂
      ≥49.6 mg/mL
      insoluble in H2O

8 件产品

每页